Remtolumab Antibody is a research-grade biosimilar monoclonal antibody targeting CTLA-8. Format: [VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer (human host). Reactivity: Human. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% as determined by SDS-PAGE. For research use only.
Remtolumab (ABT-122) is a dual-variable domain immunoglobulin that neutralises both tumor necrosis factor α (TNFα) and IL-17A. Remtolumab shows dual inhibition of TNFα and IL-17A. Remtolumab can be used for rheumatoid arthritis (RA) research.
Product Name:
Remtolumab Antibody
SKU:
GXBS00024
Size:
100 µg, 1 mg
Antibody Type:
Monoclonal Antibody
Target:
CTLA-8
Isotype:
[VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer
Host Species:
Human
Reactivity:
Human
Applications:
ELISA, FCM, Functional assay, Research in vivo
Synonyms:
Bispecific, A-1230717, ABT-122, 1791410-27-9
Purity:
>95% as determined by SDS-PAGE.
Endotoxin Level:
< 10 EU/mg
Formulation:
0.01M PBS pH 7.4.
State of Matter:
Liquid
Regulatory Status:
For research use only. Not suitable for clinical or therapeutic use.
Product Preparation:
Protein A/G purified from cell culture supernatant.
Storage and Handling:
Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
